Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$166.24M
↑ 238% above average
Average (8y)
$49.18M
Historical baseline
Range
High:$166.24M
Low:$1.07M
CAGR
+88.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $166.24M | +22.9% |
| 2023 | $135.27M | +54.4% |
| 2022 | $87.61M | +141.5% |
| 2021 | $36.27M | +226.6% |
| 2020 | $11.11M | +892.6% |
| 2019 | $1.12M | -53.8% |
| 2018 | $2.42M | +56.1% |
| 2017 | $1.55M | +45.5% |
| 2016 | $1.07M | - |